3B RISTOW MR,G ILBERT EM,ABRAHAM WT,ET AL.CARVED ILOL PRODUCESDOSE-RELATED IMPROVEM ENTS IN LEFT VENTRICU LAR FUNCTION AND SURVIVAL INSUB JECTS W ITH CHRON IC HEART FAILURE.MOCHA INVESTIGATORS[].C IRCU LATION.1996
4Packer M,Colucci W S,Sackner-Bernstein J D,et al.Double-blind, placebo-controlled study of the effects of carvedilol in patients with moderate to severe heart failure.The PRECISE Trial. Prospective randomized evaluation of cavedilol on symptoms and exercise[].Circulation.1996
5Waagstein F,Bristow MR,Swedberg R,et al.Beneficial effects of metoprolol in idiopathic dilated cardiomyopathy.Metoprolol in Dilated Cardiomyopathy (MDC) Trial Study Group[].The Lancet.1993
6Pinamonti B,Zecchin M,Lenarda A,et al.Persistence of restrictive left ventricular filling pattern in dilated cardiomyopathy: an ominous prognostic sign[].Journal of the American College of Cardiology.1997
7Steimle AE,Stevenson LW,Fonarow GC,et al.Prediction of improvement in recent onset cardiomyopathy after referral for heart transplantation[].Journal of the American College of Cardiology.1994
8Hall SA,Cigarroa CG,Marcoux L,et al.Time course of improvement in left ventricular function, mass and geometry in patients with congestive heart failure treated with beta-adrenergic blockade[].Journal of the American College of Cardiology.1995
9Eric J,Eichhorn MD,Michael R,et al.Practical Guidlines for initiation of beta-adrenergic blockade in patients with chronic heart failure[].The American Journal of Cardiology.1997
10Bristow MK,O′Connell JB,Gilbert EM,et al.Dose-response of chronic beta-blocker treatment in heart failure from either idopathic dilated or ischemic cardiomyopathy[].Circulation.1994
